Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892

Fritz Schröder; P Whelan; TM de Reijke; KH Kurth; M Pavone- Macaluso; J Mattelaer; RF van Velthoven; M Debois; L Collette

doi:10.1016/j.eururo.2003.11.016

Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892

Fritz Schröder, P Whelan, TM de Reijke, KH Kurth, M Pavone- Macaluso, J Mattelaer, RF van Velthoven, M Debois, L Collette

Urology

Research output: Contribution to journal › Article › Academic › peer-review

64 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	457-464
Number of pages	8
Journal	European Urology
Volume	45
DOIs	https://doi.org/10.1016/j.eururo.2003.11.016
Publication status	Published - 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2003.11.016

http://hdl.handle.net/1765/60535

Cite this

Schröder, F., Whelan, P., de Reijke, TM., Kurth, KH., Pavone- Macaluso, M., Mattelaer, J., van Velthoven, RF., Debois, M., & Collette, L. (2004). Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892. European Urology, 45, 457-464. https://doi.org/10.1016/j.eururo.2003.11.016

@article{f67a1af8f9fc499cb0c50611cfa08aa2,

title = "Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the {"}European Organization for Research and Treatment of Cancer{"} (EORTC) Protocol 30892",

author = "Fritz Schr{\"o}der and P Whelan and {de Reijke}, TM and KH Kurth and {Pavone- Macaluso}, M and J Mattelaer and {van Velthoven}, RF and M Debois and L Collette",

year = "2004",

doi = "10.1016/j.eururo.2003.11.016",

language = "Undefined/Unknown",

volume = "45",

pages = "457--464",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

}

Schröder, F, Whelan, P, de Reijke, TM, Kurth, KH, Pavone- Macaluso, M, Mattelaer, J, van Velthoven, RF, Debois, M & Collette, L 2004, 'Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892', European Urology, vol. 45, pp. 457-464. https://doi.org/10.1016/j.eururo.2003.11.016

TY - JOUR

T1 - Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892

AU - Schröder, Fritz

AU - Whelan, P

AU - de Reijke, TM

AU - Kurth, KH

AU - Pavone- Macaluso, M

AU - Mattelaer, J

AU - van Velthoven, RF

AU - Debois, M

AU - Collette, L

PY - 2004

Y1 - 2004

U2 - 10.1016/j.eururo.2003.11.016

DO - 10.1016/j.eururo.2003.11.016

M3 - Article

C2 - 15041109

SN - 0302-2838

VL - 45

SP - 457

EP - 464

JO - European Urology

JF - European Urology

ER -